What is Curesponse?
Curesponse operates at the intersection of oncology and data science, developing a proprietary platform named cResponse. This technology is designed to accurately and efficiently predict a patient's response to various cancer treatments. By providing timely insights, Curesponse aims to empower clinicians and patients in making more informed therapeutic decisions, thereby optimizing treatment efficacy and patient outcomes in the complex field of cancer care. The company's focus on precision medicine positions it as a key player in the evolving landscape of cancer therapeutics.
How much funding has Curesponse raised?
Curesponse has raised a total of $14M across 2 funding rounds:
Series A
$6M
Unspecified
$8M
Series A (2020): $6M with participation from aMoon and NCL Technology Ventures Ltd
Unspecified (2021): $8M, investors not publicly disclosed
Key Investors in Curesponse
aMoon
aMoon is a venture capital firm that typically invests in early-stage and growth-stage companies within the life sciences and healthcare sectors, focusing on innovative technologies that have the potential to transform patient care.
NCL Technology Ventures Ltd
NCL Technology Ventures Ltd is an investment entity that supports technology-driven companies. Specific investment focus areas are not detailed, but it participates in significant funding rounds.
What's next for Curesponse?
With the recent major strategic investment and a substantial total funding amount, Curesponse is poised for significant growth and expansion. The enterprise-level funding suggests a focus on scaling operations, advancing its cResponse platform through further research and development, and potentially broadening its market reach. This strategic backing is likely to accelerate the company's mission to revolutionize cancer treatment selection, reinforcing its position in the competitive precision medicine sector. Future developments may include strategic partnerships and broader clinical validation of its predictive capabilities.
See full Curesponse company page
